Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Blood|May 15, 1995
CD16+ monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony-stimulating factorM N Saleh, S J Goldman, A F LoBuglio, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1991
Pharmacokinetics, immune response, and biodistribution of iodine-131-labeled chimeric mouse/human IgG1,k 17-1A monoclonal antibodyR F Meredith, A F LoBuglio, W E Plott, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1996
Intraperitoneal radioimmunotherapy of ovarian cancer with lutetium-177-CC49R F Meredith, E E Partridge, R D Alvarez, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 18, 2001
Intraperitoneal radioimmunochemotherapy of ovarian cancer: a phase I studyR F Meredith, R D Alvarez, E E Partridge, et al.
Gynecologic Oncology|April 1, 1997
Intraperitoneal radioimmunotherapy of ovarian cancer with 177Lu-CC49: a phase I/II studyR D Alvarez, E E Partridge, M B Khazaeli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancerF Robert, M P Ezekiel, S A Spencer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Polynucleotide immunization of nonhuman primates against carcinoembryonic antigenR M Conry, S A White, P N Fultz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2000
Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancersJ A Bonner, K P Raisch, H Q Trummell, et al.
Journal of the National Cancer Institute|July 5, 2001
National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000P Eifel, J A Axelson, J Costa, et al.
Pageof 13